Long-term use of acamprosate calcium for alcoholism: a review of the clinical effectiveness, safety, and guidelines
CADTH
Record ID 32018002179
English
Authors' objectives:
The purpose of this report is to review the available evidence on the clinical effectiveness and safety for long term (> 1 year) use of acamprosate to treat adults with alcoholism and to review evidence-based guidelines on the use of acamprosate for treating alcoholism.
Details
Project Status:
Completed
URL for project:
https://cadth.ca/long-term-use-acamprosate-calcium-alcoholism-review-clinical-effectiveness-safety-and-guidelines
Year Published:
2015
URL for published report:
https://www.cadth.ca/sites/default/files/pdf/htis/may-2015/RC0661%20Campral%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Canada
Pubmed ID:
26180876
MeSH Terms
- Alcoholism
- Acamprosate
- Alcohol Deterrents
Keywords
- Alcoholism
- Acamprosate calcium
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.